CAI Q1 2020 Earnings — Caris Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

CAICaris Life Sciences, Inc.

$5B

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$105M-5.5% YoY

Gross Profit

$51M48.7% margin

Operating Income

$34M32.0% margin

Net Income

-$1M-1.3% margin

EPS (Diluted)

$-0.08

QoQ Revenue Growth

+4.8%

Cash Flow

Operating Cash Flow

$60M

Free Cash Flow

$32M

Stock-Based Comp.

$874,000

Balance Sheet

Total Assets

$2.9B

Total Liabilities

$2.2B

Stockholders' Equity

$690M

Cash & Equivalents

$109M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$105M	$111M	-5.5%
Gross Profit	$51M	$55M	-6.7%
Operating Income	$34M	$35M	-4.8%
Net Income	-$1M	$19M	-107.2%